Alon Ben-Noon
CIK: 0001901198
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRSN
NeuroSense Therapeutics Ltd.
Officer
Discretionary Trading P&L
Holdings
About Ben-Noon Alon
Ben-Noon Alon (SEC CIK 0001901198) files insider reports with the SEC as Chief Executive Officer of NeuroSense Therapeutics Ltd. (NRSN).
Signal8 holds 2 ownership filings by Ben-Noon Alon (1 Form 3, 1 Form 4), filed between Mar 30, 2026 and Jun 17, 2026. Those filings report 1 transaction, the latest on Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ben-Noon Alon's filings is in HERZLIYA.
Recent filings by Ben-Noon Alon
- Jun 16, 2026: Open-market purchase of NRSN shares (Form 4, code P).
Other insiders filing for NeuroSense Therapeutics Ltd. (NRSN)
- Eisenberg Or, Chief Financial Officer
- Russek-Blum Niva, Chief Technology Officer
- Binder Hagit, General Manager
- Pellizzari Christine A, Director
- Tracik Ferenc, Chief Medical Officer
- Claiborne Cary J, Director